This session, Achieving Net Zero in Pharma Manufacturing: Case Study, Challenges and Pathways, will explore how Takeda will achieve their NetZero goals by 2035 and AstraZeneca's 'Ambition Zero Carbon' strategy to eliminate emissions by 2026 and be carbon negative across the entire value chain by 2030. The speakers will discuss the current issues and challenges, including the impact of regulatory compliance and quality control on sustainable design practices. They will also delve into the pathways towards achieving NetZero, the impacts of introducing new products, and the constraints on existing facility systems infrastructure operations and monitoring. Additionally, our expert speakers will share their experiences, learnings, and best practices for achieving NetZero in pharmaceutical manufacturing.
1345 - 1415: AstraZeneca Carbon Zero Strategy by Hamid Teimourian & Justin McGarvey 1415 - 1450: Sustainable Manufacturing of Plasma-Derived Therapies: From an Idea to Reality by Geoffrey Pot 1450 - 1515: Question and Answer/Panel Discussion moderated by Amanat Kaur